USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Analysis of the Pharmaceutical Market in Malaysia
Analysis of the Pharmaceutical Market in Malaysia
Attractiveness and Hurdles for Stakeholders in the Next 5 Years
RELEASE DATE
16-Jun-2015
16-Jun-2015
REGION
North America
North America
Research Code: 9AB9-00-22-00-00
SKU: LS00071-NA-MR_16912
$1,500.00
In stock
SKU
LS00071-NA-MR_16912
Description
The growing population base, driven by increased life expectancy and domestic investment, is expected to continuously accelerate GDP in Malaysia. Significant growth of healthcare expenditure is expected in the country to facilitate the improvement of medical access and provide companies with revenue-earning opportunities from 2015. Positive macroeconomic and healthcare market trends are expected to fast-track the pharmaceutical market in Malaysia. The study explores the broad competitive landscape, demand dynamics, and regulatory environment that investors must consider while entering this pharmaceutical market.
Table of Contents
Key Findings
Key Questions this Study will Answer
Overview of the Malaysian Healthcare Market
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of Malaysian Public and Private Healthcare Systems
Overview of Malaysian Public and Private Healthcare Systems (continued)
Algorithm of Malaysian Healthcare Systems
Algorithm of Private Healthcare Systems
Future Roadblocks
Distribution of Household Income Up to 2012
Key Driver in the Malaysian Hospital Market—Growing Admission of Elderly Population
Key Driver in the Malaysian Private Hospital Segment—Medical Tourism
Key Drivers in the Malaysian Hospital Market—Chronic and Lifestyle Diseases
Overview of the Malaysian Pharmaceutical Market
Revenue Forecast for the Malaysian Pharmaceutical Market
Pharmaceutical Market Components by Percentage
Malaysian Pharmaceutical Market—Segmentation
Malaysian Pharmaceutical Market—Segmentation (continued)
Halal Medicine Market in Malaysia
Malaysian Regulatory Landscape
Key Driver in the Malaysian Pharmaceutical Market—NKEA
Impact of GST on Malaysian Pharmaceutical Market
Drivers
Restraints
Home-grown Participants in the Malaysian Pharmaceutical Market
CCM Pharmaceuticals Sdn Bhd
Kotra Pharma (M) Sdn Bhd
Pharmaniaga Berhad
YSP Industries (M) Sdn Bhd
Hovid Berhad
MNC Participants in the Malaysian Pharmaceutical Market
Pfizer Malaysia
Merck Sharp & Dohme (MSD)
Eli Lilly
GlaxoSmithKline (GSK)
Johnson & Johnson Sdn Bhd
PESTLE Analysis
Porter Five Forces Analysis for the Malaysian Pharmaceutical Market
The Future of the Malaysian Pharmaceutical Market—Key Focus Areas
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
This research service focuses on the 4 broad segments of the regenerative medicine market, namely cell therapy, gene therapy, tissue engineering, and small molecules and biologics. A detailed overview of the cell therapy segment, including the major commercialised products and products in development, has been provided. Additionally, key clinical milestones, timelines of key clinical events, key companies to watch, and a strategic partnership assessment in the global regenerative market have been included. An overview of the other segmentsgene therapy, tissue engineering, and small molecules and biologicshas also been provided.
| No Index | No |
|---|---|
| Podcast | No |
| Lightbox Content | World Cancer Day 2019|Get 15% discount for all Healthcare studies |https://store.frost.com/contacts/?utm_source=PD&utm_medium=lightbox&utm_campaign=HEALTHCARE_CANCER2019 |
| Author | Rageshwary Ramupillai |
| WIP Number | 9AB9-00-22-00-00 |
| Is Prebook | No |